DBV Technologies SA
(NAS:DBVT)
$
3.9
0.835 (27.24%)
Market Cap: 68.07 Mil
Enterprise Value: 29.75 Mil
PE Ratio: 0
PB Ratio: 1.32
GF Score: 39/100 DBV Technologies SA at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2020 / 05:30PM GMT
Release Date Price:
$24.5
(-5.41%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
Hello, everyone. My name is Evan Seigerman. I'm the senior biopharma analyst here at Crédit Suisse, and welcome to day 3 of our virtual Global Healthcare Conference. We are looking forward to hopefully seeing everyone in person next year. But with me today, I have DBVT, and from DBVT, I have CEO, Daniel Tassé. Thank you, Dan, for joining us.
Daniel TassÃ;DBV Technologies S.A.;CEO;Director
©,-&
Thanks for having me.
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
I believe the last time we saw each other was in January, where I was joking that you gave me some peanut M&Ms, how appropriate. But it's been quite a year. I kind of -- it would be great if you could just get us up to speed as to where DBVT is now and kind of what to look forward to, and then I'm going to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot